Volume 40, Issue 2 pp. 142-143
Full Access

The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride

William L. Smith

Corresponding Author

William L. Smith

Department of Pharmacology, Office of Research, A. H. Robins Company, Inc., Richmond, Virginia 23220, USA

Department of Pharmacology, A. H. Robins Company, Inc., 1211 Sherwood Avenue, Richmond, Virginia 23220, USA.Search for more papers by this author
Esther M. Callaham

Esther M. Callaham

Department of Pharmacology, Office of Research, A. H. Robins Company, Inc., Richmond, Virginia 23220, USA

Search for more papers by this author
Reevis S. Alphin

Reevis S. Alphin

Department of Pharmacology, Office of Research, A. H. Robins Company, Inc., Richmond, Virginia 23220, USA

Search for more papers by this author
First published: February 1988
Citations: 59

Abstract

Abstract— Cisplatin administered by either the intravenous (i.v.) or intra-cerebroventricular (i.c.v.) route produced emesis in cats. The average time to onset of emesis was decreased significantly (4.0 min versus 100.6 min) when cisplatin was administered i.c.v. Zacopride administered either i.c.v. (0.02 mg) or i.v. (0.1 mg kg−1) completely blocked the emesis due to cisplatin given by either route. Their data show that cisplatin possesses a central emetic component and that this is blocked by zacopride.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.